175 related articles for article (PubMed ID: 35414467)
21. A new kid on the block: Outcomes with Kcentra 1 year after approval.
Berndtson AE; Huang WT; Box K; Kobayashi L; Godat LN; Smith AM; Weingarten D; Coimbra R
J Trauma Acute Care Surg; 2015 Dec; 79(6):1004-8. PubMed ID: 26488322
[TBL] [Abstract][Full Text] [Related]
22. Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage.
Ammar AA; Ammar MA; Owusu KA; Brown SC; Kaddouh F; Elsamadicy AA; Acosta JN; Falcone GJ
Neurocrit Care; 2021 Aug; 35(1):255-261. PubMed ID: 33403588
[TBL] [Abstract][Full Text] [Related]
23. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
Pinner NA; Hurdle AC; Oliphant C; Reaves A; Lobo B; Sills A
World Neurosurg; 2010 Dec; 74(6):631-5. PubMed ID: 21492631
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage.
Pasciolla S; Wojcik K; Kavi T; Green D; Shaikh H; Jankowitz B; Igneri LA
J Thromb Thrombolysis; 2022 Jul; 54(1):74-81. PubMed ID: 34837144
[TBL] [Abstract][Full Text] [Related]
25. Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage.
Townsend B; Slechta J; Gilbert BW
Am J Emerg Med; 2024 Feb; 76():136-139. PubMed ID: 38071882
[TBL] [Abstract][Full Text] [Related]
26. Emergent reversal of vitamin K antagonists: addressing all the factors.
Martin DT; Barton CA; Dodgion C; Schreiber M
Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
[TBL] [Abstract][Full Text] [Related]
27. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
28. Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol.
Fuh L; Goldstein JN; Hayes BD
J Thromb Thrombolysis; 2020 Jul; 50(1):217-220. PubMed ID: 31707622
[TBL] [Abstract][Full Text] [Related]
29. Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices.
Rimsans J; Levesque A; Lyons E; Sylvester K; Givertz MM; Mehra MR; Stewart GC; Connors JM
J Thromb Thrombolysis; 2018 Aug; 46(2):180-185. PubMed ID: 29785470
[TBL] [Abstract][Full Text] [Related]
30. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
[TBL] [Abstract][Full Text] [Related]
31. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
32. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients.
Edavettal M; Rogers A; Rogers F; Horst M; Leng W
Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Hemostatic Outcomes in Patients Receiving Fixed-Dose vs. Weight-Based 4-Factor Prothrombin Complex Concentrate.
Kim C; Cottingham L; Eberwein K; Komyathy K; Ratliff PD
J Emerg Med; 2020 Jul; 59(1):25-32. PubMed ID: 32536491
[TBL] [Abstract][Full Text] [Related]
34. Fixed-dose prothrombin complex concentrate for emergent warfarin reversal among patients with intracranial hemorrhage.
Dietrich SK; Mixon MA; Rech MA
Am J Emerg Med; 2021 Nov; 49():326-330. PubMed ID: 34224954
[TBL] [Abstract][Full Text] [Related]
35. Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience.
Mačiukaitienė J; Bilskienė D; Tamašauskas A; Bunevičius A
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344253
[No Abstract] [Full Text] [Related]
36. Reversal of coagulopathy using prothrombin complex concentrates is associated with improved outcome compared to fresh frozen plasma in warfarin-associated intracranial hemorrhage.
Frontera JA; Gordon E; Zach V; Jovine M; Uchino K; Hussain MS; Aledort L
Neurocrit Care; 2014 Dec; 21(3):397-406. PubMed ID: 24671832
[TBL] [Abstract][Full Text] [Related]
37. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS
Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592
[TBL] [Abstract][Full Text] [Related]
38. Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage.
Vestal ML; Hodulik K; Mando-Vandrick J; James ML; Ortel TL; Fuller M; Notini M; Friedland M; Welsby IJ
J Thromb Thrombolysis; 2022 Jan; 53(1):167-175. PubMed ID: 34101050
[TBL] [Abstract][Full Text] [Related]
39. Low-Dose Prothrombin Complex Concentrate in Patients with Left Ventricular Assist Devices.
Brown CS; Zemrak WR; Dyer KJ; Rolfe S
ASAIO J; 2019 Feb; 65(2):e21-e24. PubMed ID: 29561270
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes after 4F-PCC for warfarin-associated ICH and baseline GCS less than or equal to 8.
Koehl KE; Panos NG; Peksa GD; Slocum GW
Am J Emerg Med; 2022 Sep; 59():59-62. PubMed ID: 35785611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
